Qitao Yu
- Oncology top 10%
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 4
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 3
-
- Lung Cancer Treatments and Mutations 22
- Lung Cancer Diagnosis and Treatment 8
-
- Radiomics and Machine Learning in Medical Imaging 4
- Co-authors
- Shaozhang ZhouAiping ZengWei JiangJianbo HeXiangqun SongTao LiYu ZhangMin Luo
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Qitao Yu
33 papers receiving 488 citations
Peers
Comparison fields: 5 of 60
- Oncology 284
- Cancer Research 147
- Pulmonary and Respiratory Medicine 219
- Molecular Biology 188
- Otorhinolaryngology 10
Countries citing papers authored by Qitao Yu
This map shows the geographic impact of Qitao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qitao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qitao Yu more than expected).
Fields of papers citing papers by Qitao Yu
This network shows the impact of papers produced by Qitao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qitao Yu. The network helps show where Qitao Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qitao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 37 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 39 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 42 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 15 | |
| 16 | 2018 | 12 | |
| 17 | 2018 | 7 | |
| 18 | 2015 | 2 | |
| 19 | 2014 | 35 | |
| 20 | Detection of EML4-ALK fusion gene and analysis of its clinical features in NSCLC patients with EGFR mutation | 2012 | 2 |
About Qitao Yu
Qitao Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 35 papers that have together received 489 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (11 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (284 citations), Cancer Research (147 citations) and Pulmonary and Respiratory Medicine (219 citations). Qitao Yu has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Shaozhang Zhou, Aiping Zeng, Wei Jiang, Jianbo He, Xiangqun Song, Tao Li, Yu Zhang, Min Luo, Wenhua Zhao and Huilin Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.